These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1611970)

  • 1. [Helicobacter pylori: from harmless commensal to clinically significant disease factor].
    Labenz J; Börsch G
    Dtsch Med Wochenschr; 1992 Jun; 117(25):997-9. PubMed ID: 1611970
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple therapy and Helicobacter pylori.
    Davis S
    Aust Fam Physician; 1996 Jan; 25(1):53, 56-9. PubMed ID: 8607776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Helicobacter pylori and gastrointestinal tract diseases].
    Riis JS; Willoch C; Aase S
    Tidsskr Nor Laegeforen; 1992 Aug; 112(18):2353-5. PubMed ID: 1412235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].
    Sobhani I; Flourié B; Lavergne A; Colimon R; Mignon M; Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1991; 15(5):412-20. PubMed ID: 2070962
    [No Abstract]   [Full Text] [Related]  

  • 6. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
    Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
    Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
    Maniatis AG; Brazer SR
    Am J Gastroenterol; 1994 Jun; 89(6):947-8. PubMed ID: 8198114
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
    Sung JJ; Leung VK; Chung SC; Ling TK; Suen R; Cheng AF; Li AK
    Am J Gastroenterol; 1995 Sep; 90(9):1424-7. PubMed ID: 7661162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
    Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
    Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
    Gisbert JP; Boixeda D; de Rafael L; Redondo C; Martín de Argila C; Bermejo F
    Rev Esp Enferm Dig; 1996 May; 88(5):317-22. PubMed ID: 8764537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
    Carnicer J
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():25-8. PubMed ID: 9549199
    [No Abstract]   [Full Text] [Related]  

  • 16. [When should Helicobacter pylori be eradicated?].
    Buckley M; O'Morain C
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S95-S102. PubMed ID: 8734377
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Cure" of Helicobacter pylori and "cure" of peptic ulcer: do they mean the same thing?
    Fennerty MB
    Am J Gastroenterol; 1995 Aug; 90(8):1203-4. PubMed ID: 7639214
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient factors affecting Helicobacter pylori eradication with triple therapy.
    Cutler AF; Schubert TT
    Am J Gastroenterol; 1993 Apr; 88(4):505-9. PubMed ID: 8470629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.